Jee Hyun Kim
Seoul National University Bundang Hospital
763 Papers
1.9K Citations
Jee Hyun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 319 publications. Previous affiliations of Jee Hyun Kim include Seoul National University & New Generation University College.
Chat about Author
Papers
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.
Sung Bum Kang,Ji Won Park,Seung-Yong Jeong,Byung-Ho Nam,Hyo Seong Choi,Duck-Woo Kim,Seok-Byung Lim,Taek-Gu Lee,Dae Yong Kim,Jae Sung Kim,Hee Jin Chang,Hye Seung Lee,Sun Young Kim,Kyung Hae Jung,Yong Sang Hong,Jee Hyun Kim,Dae Kyung Sohn,Dae-Hyun Kim,Jae Hwan Oh +18 more
TL;DR: The laparoscopic surgery group showed earlier recovery of bowel function than the open surgery group, and Involvement of the circumferential resection margin, macroscopic quality of the total mesorectal excision specimen, and perioperative morbidity did not differ between the two groups.
998
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
Seung-Yong Jeong,Seung-Yong Jeong,Ji Won Park,Ji Won Park,Byung-Ho Nam,Sohee Kim,Sung Bum Kang,Seok Byung Lim,Hyo Seong Choi,Duck Woo Kim,Hee Jin Chang,Dae Yong Kim,Kyung Hae Jung,Tae You Kim,Gyeong Hoon Kang,Eui Kyu Chie,Sun-Young Kim,Dae Kyung Sohn,Dae-Hyun Kim,Jae Sung Kim,Hye Seung Lee,Jee Hyun Kim,Jae Hwan Oh +22 more
TL;DR: The results show that laparoscopic resection for locally advanced rectal cancer after preoperative chemoradiotherapy provides similar outcomes for disease-free survival as open resection, thus justifying its use.
826
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Javier Cortes,Sung-Bae Kim,W-P. Chung,Seock-Ah Im,Yeon Hee Park,Roberto Hegg,Min Hwan Kim,Ling Ming Tseng,Vanessa Petry,Chi-Feng Chung,Hiroji Iwata,Erika Hamilton,Giuseppe Curigliano,Bing Xue,Chiun-Sheng Huang,Jee Hyun Kim,Joanne Chiu,Jose Luiz Pedrini,Caleb Lee,Yali Liu,Jillian Cathcart,Emarjola Bako,Sunil Verma,Sara A. Hurvitz +23 more
TL;DR: Among patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and a taxane, the risk of disease progression or death was lower among those who received trastudumab deruxtecan than amongThose who receivedtrastuzuab emtansine.
445
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Yong Sang Hong,Byung-Ho Nam,Kyu Pyo Kim,Jeong Eun Kim,Seong Joon Park,Young Suk Park,Joon Oh Park,Sun-Young Kim,Tae You Kim,Jee Hyun Kim,Joong Bae Ahn,Seok Byung Lim,Chang Sik Yu,Jin Cheon Kim,Seong Hyeon Yun,Jong Hoon Kim,Jin-Hong Park,Hee Chul Park,Kyung Hae Jung,Tae Won Kim +19 more
TL;DR: This open-label, multicentre, phase 2, randomised trial aimed to compare the efficacy and safety of adjuvant fluorouracil and leucovorin with that of FOLFOX in patients with locally advanced rectal cancer after preoperative chemoradiotherapy.
382
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
Anna Seo,Heuiran Lee,Eun-Joo Kim,Hyun-Jib Kim,Mirim Jang,Hongeun Lee,Yi Jun Kim,Yi Jun Kim,Jee Hyun Kim,Jee Hyun Kim,So Yeon Park,So Yeon Park +11 more
TL;DR: Findings indicate that CD8+ cytotoxic T lymphocytes are a key component of TILs associated with chemo-response and can be used as a reliable predictor of response to anthracycline- or anthrACYcline/taxane-based PST in breast cancer.